Found 46 matching trials
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
PHASE3This study is planned to evaluate the safety (in terms of occurrence of any...
Location
GSK Investigational Site
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
N/AThis study aims to evaluate the effectiveness of Rotarix™ vaccine in the ge...
Location
GSK Investigational Site
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
N/AThis study aims to estimate the effectiveness of Rotarix™ vaccine which is ...
Location
GSK Investigational Site
Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand
PHASE3Primary Objective:
To demonstrate the non-inferiority of the SHAN6™ vaccin...
Location
Investigational Site Number 7640003
Treatments Being Tested
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus)DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b)Inactivated Poliomyelitis VaccinePoliomyelitis Vaccine bivalent types 1 and 3Human Rotavirus, live attenuatedPneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
N/AThe main aim of this study is to investigate cases of rotavirus gastroenter...
Location
GSK Investigational Site
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
PHASE2This study will evaluate the safety and immunogenicity of GSK Biologicals' ...
Location
GSK Investigational Site
Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants
PHASE3The primary objective of this study is to determine if the GSK Biologicals'...
Location
GSK Investigational Site
Study to Evaluate the Safety of Rotarix™ in Chinese Children
PHASE1The purpose of this study is to assess the safety of Rotarix ™ when adminis...
Location
GSK Investigational Site
Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children
N/AThe purpose of this study is to assess vaccine effectiveness of Rotarix in ...
Location
GSK Investigational Site
Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.
PHASE3To assess the long-term efficacy and safety of the subjects during the thir...
Location
GSK Investigational Site